Abstract:Abstract Background Accumulating evidence indicates that dysregulation of miR-182-5p can serve as diagnostic and prognostic biomarkers for some cancers, whereas the role of miR-182-5p has not been explored in nasopharyngeal carcinoma (NPC). Our study aims to elucidate the biological function of miR-182-5p in NPC and the potential molecular mechanism involved. Methods Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to determine miR-182-5p expression in NPC primary tissues and cell lines. Immunohistochemistry (IHC) for ZFP36L1 was conducted in NPC samples. Western blot was used to evaluate protein expression in cell lines. A series of functional assays were carried out to evaluate the roles of miR-182-5p and ZFP36L1 in tumor development and progression of NPC. Bioinformatics tools and luciferase reporter assays were utilized to identify the potential mechanisms of action. Moreover, rescue experiments were applied to explore whether ZFP36L1 mediated the effects of miR-182-5p in NPC. Results Up-regulation of miR-182-5p was significantly associated with tumor development and poor prognosis in patients with NPC. Functional study demonstrated that miR-182-5p overexpression enhanced, whereas suppression of miR-182-5p impeded NPC cell proliferation, migration, tumorigenesis and metastasis. Mechanistically, miR-182-5p interacted with ZFP36L1 at two sites in its 3′ un-translated region (UTR) and repressed ZFP36L1 expression in NPC. Consistently, an inverse correlation was observed between the expression levels of miR-182-5p and ZFP36L1 using clinical NPC tissues, and down-regulation of ZFP36L1 in NPC predicts poor survival. Furthermore, overexpression of miR-182-5p in NPC was partly attributable to the transcriptional activation effect induced by hypoxia-inducible factor 1α (HIF-1α). Conclusions Our data suggests that miR-182-5p facilitates cell proliferation and migration in NPC through its ability to down-regulate ZFP36L1 expression, and that the HIF-1α/miR-182-5p/ZFP36L1 axis may serve as a novel therapeutic target in the management of NPC.

Knockdown of Mir-214 Promotes Apoptosis and Inhibits Cell Proliferation in Nasopharyngeal Carcinoma

Mir-18A Downregulates DICER1 and Promotes Proliferation and Metastasis of Nasopharyngeal Carcinoma.

Mir-92A is a Critical Regulator of the Apoptosis Pathway in Glioblastoma with Inverse Expression of BCL2L11.

Mir-9 Targets CXCR4 and Functions As a Potential Tumor Suppressor in Nasopharyngeal Carcinoma.

Microrna-152 Inhibits Cell Proliferation, Migration and Invasion by Directly Targeting Mafb in Nasopharyngeal Carcinoma

MicroRNA-15a Inhibits Proliferation and Induces Apoptosis in CNE1 Nasopharyngeal Carcinoma Cells

MiR-663, a Microrna Targeting P21waf1/cip1, Promotes the Proliferation and Tumorigenesis of Nasopharyngeal Carcinoma

MicroRNA Deregulation and Pathway Alterations in Nasopharyngeal Carcinoma.

miR-29a/b Enhances Cell Migration and Invasion in Nasopharyngeal Carcinoma Progression by Regulating SPARC and COL3A1 Gene Expression

Mir-421 Induces Cell Proliferation and Apoptosis Resistance in Human Nasopharyngeal Carcinoma Via Downregulation of Foxo4

MicroRNA-372 Enhances Radiosensitivity While Inhibiting Cell Invasion and Metastasis in Nasopharyngeal Carcinoma Through Activating the PBK-dependent P53 Signaling Pathway

Mir-185-3p Regulates Nasopharyngeal Carcinoma Radioresistance by Targeting WNT2B in Vitro.

Silencing of Lncrna MIR31HG Promotes Nasopharyngeal Carcinoma Cell Proliferation and Inhibits Apoptosis Through Suppressing the PI3K/AKT Signaling Pathway.

The oncogenic role of HIF-1α/miR-182-5p/ZFP36L1 signaling pathway in nasopharyngeal carcinoma

LncRNA MIR100HG Promotes Cell Proliferation in Nasopharyngeal Carcinoma by Targeting miR-136-5p/IL-6 Axis

MicroRNA-215 promoted the progression of nasopharyngeal carcinoma through targeting RB1 and activating Wnt/β-catenin pathway.

MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1 alpha in nasopharyngeal carcinoma

Microrna Expression Profiling of Nasopharyngeal Carcinoma.

MicroRNA-613 Enhances Nasopharyngeal Carcinoma Cell Radiosensitivity via the DNA Methyltransferase 3B/ Tissue Inhibitor of Matrix Metalloproteinase-3/Signal Transducer and Activator of Transcription-1/Forkhead Box O-1 Axis

Retracted: Mir-125b Increases Nasopharyngeal Carcinoma Radioresistance By Targeting A20/Nf-Kappa B Signaling Pathway (Retracted Article. See Vol. 17, Pg. 2490, 2018)

Mirna-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting Il8/Akt Signaling